<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="../../external.html?link=http://www.w3.org/1999/xhtml"><head><title>Issues Berkeley Medical Journal</title>



  

  
  
  <meta http-equiv="content-language" content="English" />

  
  <meta name="description" content="ISSUES Berkeley Medical Journal--Berkeley undergraduate science, medicine, and health journalism." />

  
  <meta name="keywords" content="Issues, berkeley, university, california, journalism, science, medicine, undergraduate, journal, ISSUES Berkeley Medical Journal, Issues Berkeley" />

  
  <meta name="owner" content="ISSUES Berkeley Medical Journal" />

  
  <meta name="revisit-after" content="20 days" />

  
  <meta name="rating" content="General" />

  
  <meta name="robots" content="all" />

  
  <link rel="stylesheet" type="text/css" href="../style.css" /></head><body>
<div id="container">
<!--

******************************

	Header + Navigation

******************************

-->
<div id="header"><a href="../index.html"><img src="../images/logo.jpg" style="border: 0px solid ; float: left; width: 246px; height: 40px;" alt="" align="left" /></a></div>
<div id="nav">
<ul>
  <li><a href="../contactus.html" title="Contact Us">Contact&nbsp;Us</a></li>
  <li><a href="../archive.html" title="Publications">Archive</a></li>
  <li><a href="../courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="../aboutus.html" title="About Us">About&nbsp;Us</a></li>
  <li><a href="../index.html" title="Home">Home</a></li>
</ul>
</div>
<!--

******************************

	News Updates Column

******************************

-->
<div id="newsupdate">
<h1>Links and Updates</h1>
<div class="newstitle">.site<span>Navigation*</span></div>
<div id="MainText-left">
<ul>
  <li><a href="../index.html" title="Home">Home</a></li>
  <li><a href="../aboutus.html" title="About Us">About Us</a></li>
  <li><a href="../courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="../archive.html" title="Publications">Archive</a></li>
  <li><a href="../staff.html" title="Staff">Staff</a></li>
  <li><a href="../joinus.html" title="Opportunities">Join Us<br />
    </a></li>
  <li><a href="../advertise.html" title="Advertisements">Advertise</a></li>
  <li><a href="../contactus.html" title="Contact Us">Contact Us</a></li>
</ul>
</div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div class="newstitle"><span><br />
</span></div>
<br />
<p><b><br />
<br />
</b></p>
<div class="newstitle"><span><b><br />
</b></span></div>
<b><br />
</b>
<p><b><b><br />
<br />
<br />
<a href="../../external.html?link=http://www.ocf.berkeley.edu/">
<br />
</a> </b></b></p>
</div>
<!--

******************************

   Welcome Message IMG+TEXT

******************************

-->
<div class="rightcontainer">
<div id="welcome"><b><b>science. medicine. health.</b></b></div>
<div id="content">
<h3 style="text-align: center;">Breast Cancer's Unlikely Ally<br />
</h3>
<br />
<p style="text-align: center;">Increased estrogen renders the immune system ineffective</p>
<p style="text-align: center;">Amrita Bajwa<br />
</p>

<p style="text-align: center;">Spring 2008<br />
</p>
<p><br />
</p>
<p><small><img style="border: 0px solid ; width: 250px; height: 167px;" alt="breast cancer immune system estrogen pi-9 hormone" src="15.2_Bajwa_A_Breast_Cancers_Ally.jpg.JPG" align="right" hspace="10" vspace="10" />&nbsp;&nbsp;&nbsp;
Estrogen could be the primary determinant of enhanced growth and
motility of breast cancer cells. Originally reported by David Shapiro,
PhD, University of Illinois, and other collaborators in the January
2007 issue of Oncogene, this recent finding has created waves of
interest in the scientific community. Furthermore, this study
implicates estrogen in blocking the body&#8217;s immune response to cancer
cells by upregulating the production of an inhibitor that deters immune
cells from effectively killing tumor cells. <br />
<br />
&nbsp;&nbsp;&nbsp; The female sex hormone estrogen primarily originates
from developing follicles in the ovaries, promoting the development of
secondary sexual characteristics and regulating the menstrual cycle.
Shapiro &#8217;s study demonstrates that when estrogen binds with its cognate
receptor, the complex begins to promote the expression of a gene
encoding a particular enzyme inhibitor, proteinase inhibitor 9 (PI-9).
PI-9 prevents natural killer cells from releasing cytoplasmic enzymes
called granzymes into breast cancer cells, thus allowing the cancer
cells to evade elimination by the immune system.<br />
<br />
&nbsp;&nbsp;&nbsp; Shapiro&#8217;s research began as an endeavor to
understand the interplay between estrogen receptor activation and gene
transcription. After identifying PI-9 as an estrogen-regulated gene,
Shapiro and his colleagues discovered that estrogen actually blocks
immunosurveillance of breast cancer cells. Increasing the production of
PI-9 and SerpinB9, a closely related inhibitor, disrupts tumor cell
destruction by NK92 natural killer cells. In Shapiro&#8217;s study, high
levels of estrogen receptors allowed tamoxifen (TAM)-related signaling
to have a synergistic effect with PI-9 in preventing the destruction of
tumor cells by NK-92 cells. On the other hand, numerous experiments
involving the activation of estrogen receptors have shown that an
increase of PI-9 is also related to the production of TAM, an estrogen
receptor modulator currently used for treating early stages of breast
cancer. Thus, different levels of TAM can produce varying effects with
elevated levels of estrogen receptor, which ultimately prevents
destruction of cancer cells.<br />
<br />
&nbsp;&nbsp;&nbsp; Lillie Shockney, RN, MAS, administrative director of
the Breast Cancer Center at Johns Hopkins University, considers the
results of Shapiro&#8217;s studies &#8220;fascinating and actually supportive of
some other hypotheses that have been made in the past.&#8221; Ultimately, she
notes, &#8220;The results of this study and others will trigger the need to
re-evaluate hormones and their use.&#8221;<br />
</small></p><p><br />
</p>
<h3><b><b><b><b>About the Author<br />
</b></b></b></b></h3>
<p>
</p>
<p><small>Amrita Bajwa is a third-year Molecular and Cell Biology major and wishes to pursue a career in academic medicine.</small></p>
<p><br />
</p>
<p style="text-align: center;"><a href="15.2_Issue.html"><small>return
to issue</small></a></p>
<p style="text-align: center;"><br />
</p>
</div>
</div>
<div id="footer"> Copyright © 2008 ISSUES Berkeley Medical Journal |
Designed by MockUp | <a href="mailto:bmjwebm@gmail.com">Contact
Webmaster </a><br />
Not an official University publication. Content not necessarily
reflective of UC Berkeley or the ASUC.</div>
</div>

</body></html>